Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ikaria takes a $1.6B buyout but spins out some early-stage programs
Fierce Biotech
Thursday, December 26, 2013 - 1:57pm
tags:
Ikaria, M&A
Not all pharmaceuticals are created equal
Marketwatch
Thursday, December 26, 2013 - 1:56pm
tags:
Valeant Pharmaceuticals
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thursday, December 26, 2013 - 1:52pm
tags:
RNAi, Alnylam
Alnylam Pharmaceuticals, Inc.: The Best Performing Biotechs of 2013
Motley Fool
Thursday, December 26, 2013 - 1:51pm
tags:
Alnylam, RNAi
UK Support For Glaxo But None For Whistleblowers?
Forbes
Thursday, December 26, 2013 - 1:49pm
tags:
UK, GSK, whistleblowers, China
A Year-End Look at 3 High-Flying Biotech IPOs of 2013: PETX, RCPT, STML
Motley Fool
Thursday, December 26, 2013 - 1:48pm
tags:
IPOs, Receptos, Aratana, Stemline Therapeutics
A Not-So Fat 2013 for This Obesity-Drug Maker
Motley Fool
Thursday, December 26, 2013 - 1:47pm
tags:
obesity, Vivus, Qsymia, Eisai, Belviq, Arena Pharmaceuticals
Chinese Hepatitis Vaccine Maker Slumps After Baby Deaths: Shanghai Mover
Bloomberg
Thursday, December 26, 2013 - 10:03am
tags:
vaccines, hepatitis B, Beijing Tiantan Biological Products
4 Bold Biotech Calls For 2014
Seeking Alpha
Thursday, December 26, 2013 - 10:00am
tags:
Neuralstem, Cynapsus, Titan Pharmaceuticals
Teva seen selecting Vigodman as next CEO, Globes says
The Fly on the Wall
Thursday, December 26, 2013 - 9:59am
tags:
Teva Pharmaceuticals, Pharma CEOs, Erez Vigodman
BioCryst's Peramivir Filed in the U.S.
Yahoo/Zacks.com
Thursday, December 26, 2013 - 9:49am
tags:
Biocryst, peramivir, influenza, Flu
Merck Sues Actavis Over Generic NuvaRing
Wall St Cheat Sheet
Thursday, December 26, 2013 - 9:46am
tags:
Actavis, Merck, generics, Nuvaring, contraceptive rings
TPG-backed drugmaker Aptalis files for IPO of up to $500 mln
Reuters
Thursday, December 26, 2013 - 9:45am
tags:
IPOs, Aptalis
3 Biotechs That Could Double In 2014
Seeking Alpha
Thursday, December 26, 2013 - 9:43am
tags:
Nektar, Inovio, Arena Pharmaceuticals
Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
Seeking Alpha
Thursday, December 26, 2013 - 9:43am
tags:
eteplirsen, Sarepta Therapeutics, Duchenne Muscular Dystrophy
Exclusive: Carlyle near deal to buy J&J diagnostics unit - sources
Reuters
Tuesday, December 24, 2013 - 9:52am
tags:
Carlyle, JNJ, diagnostics, M&A
FDA rejects Actavis' contraceptive patch, asks for more data
Reuters
Tuesday, December 24, 2013 - 9:51am
tags:
FDA, Actavis, contraceptive patch
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tuesday, December 24, 2013 - 9:50am
tags:
Big Pharma, drug stocks, Merck, JNJ, GSK, Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb
Is AstraZeneca plc Set For Electrifying Earnings Growth In 2014?
Motley Fool, UK
Tuesday, December 24, 2013 - 9:48am
tags:
AstraZeneca
Is Amarin's Luck About to Change?
Motley Fool
Tuesday, December 24, 2013 - 9:48am
tags:
Amarin, Vascepa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.